LINC00926 is involved in hypoxia-induced vascular endothelial cell dysfunction via miR-3194-5p regulating JAK1/STAT3

Yong Jiang1, Chun-Hui Xu2, Ying Zhao3

  • 1Department of Laboratory Medicine, Jilin Medical University, Jilin . jiangyongpost@sina.com.

Insights

Long noncoding RNA LINC00926 worsens endothelial cell dysfunction in coronary heart disease by regulating the miR-3194-5p/JAK1/STAT3 pathway under hypoxia.

Area of Science:

  • Cardiovascular Biology
  • Molecular Biology
  • RNA Biology

Background:

  • Vascular endothelial cell (VEC) dysfunction contributes to coronary heart disease (CHD).
  • Long noncoding RNA (lncRNA) LINC00926 is dysregulated in CHD patients, but its role remains unclear.
  • Understanding LINC00926's function in endothelial cells under stress is crucial.

Purpose of the Study:

  • To investigate the regulatory mechanism of LINC00926 in human umbilical vein endothelial cells (HUVECs) exposed to hypoxia.
  • To elucidate the role of LINC00926 in endothelial cell dysfunction.

Main Methods:

  • Hypoxia exposure of HUVECs (5% O2 for 24 h).
  • RT-qPCR and Western blotting for gene and protein expression.
  • CCK-8, flow cytometry, Transwell, and angiogenesis assays for cell function.
  • Bioinformatics and dual-luciferase reporter assays to confirm molecular interactions.

Main Results:

  • LINC00926 expression was elevated in CHD patients and hypoxia-exposed HUVECs.
  • Overexpression of LINC00926 impaired HUVEC proliferation, migration, and tube formation, while increasing apoptosis.
  • LINC00926 targets miR-3194-5p, which in turn targets JAK1, modulating the JAK1/STAT3 pathway.

Conclusions:

  • LINC00926 exacerbates endothelial cell dysfunction in hypoxia via the miR-3194-5p/JAK1/STAT3 signaling axis.
  • This finding highlights LINC00926 as a potential therapeutic target for CHD-related endothelial dysfunction.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.7K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.1K
Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
5.1K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.7K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.5K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.8K